NASDAQ:ME
23andMe Holding Co. Stock News
$0.587
-0.0103 (-1.73%)
At Close: May 17, 2024
Why 23andMe Stock Was Lagging the Market Today
02:28pm, Friday, 27'th May 2022
The genetics company misses on both the top and bottom lines in its fourth quarter.
23andMe Holding Co. (ME) CEO Anne Wojcicki on Q4 2022 Results - Earnings Call Transcript
09:35pm, Thursday, 26'th May 2022
23andMe Holding Co. (NASDAQ:ME ) Q4 2022 Earnings Conference Call May 26, 2022 4:30 PM ET Company Participants Wade Walke - Vice President of Investor Relations Anne Wojcicki - Co-Founder and Chief Ex
23andMe stock falls on widening loss
06:51pm, Thursday, 26'th May 2022
Shares of 23andMe Holding Co. ME, fell almost 7% in after-hours trading after the genetic-testing company saw its loss widen for the fiscal fourth quarter, and issued guidance that assumes the loss wi
Best Penny Stocks To Buy? Einhorn, Lynch, Cohen & Dalio Own These 5
11:04am, Thursday, 19'th May 2022
Top Wall Street Investors Own These 5 Penny Stocks. Are They A Buy Now?
23andMe to Report FY2022 Fourth Quarter and Full Year Financial Results
04:10pm, Thursday, 12'th May 2022
SUNNYVALE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report financial re
23andMe CEO Anne Wojcicki on Bringing Health Information Directly to People
03:35pm, Friday, 29'th Apr 2022
A better understanding of genes could dramatically improve healthcare.
This Exciting Biotech Stock Could Be Your Next 10-Bagger
06:00am, Sunday, 10'th Apr 2022
The company's drug development program is the major key to success.
2 Beaten-Down SPACs That Could Be Long-Term Home Runs
06:33am, Thursday, 31'st Mar 2022
These stocks are down by 50% or more from the highs but could be big winners for patient investors.
23andMe to Present at American Association for Cancer Research (AACR) 2022 Annual Meeting
06:45am, Tuesday, 15'th Mar 2022
SUNNYVALE, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and therapeutics company with a mission to help people access, under
These 5 SPACs All Plummeted After Celebrities Backed Them
02:19pm, Monday, 28'th Feb 2022
Attaching a celebrity's name to a SPAC is a good way to get people excited, but these SPACs all failed despite the support of some big names. The post These 5 SPACs All Plummeted After Celebrities Bac
23andMe to Present at Cowen 42nd Annual Health Care Conference
08:30am, Friday, 25'th Feb 2022
SUNNYVALE, Calif., Feb. 25, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company with a mission to help people access, understand
23andMe: A Genetics Innovator Positioned For Growth
02:25am, Saturday, 19'th Feb 2022
23andMe Holding Co. is gearing up to capitalize on its growing genetic database by investing in new business verticals and industry-first services.
23andMe to Present at Citi's 2022 Virtual Healthcare Conference
09:00am, Thursday, 17'th Feb 2022
SUNNYVALE, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company with a mission to help people access, understand
After Falling 67% in 1 Year, Is 23andMe Undervalued?
08:52am, Wednesday, 16'th Feb 2022
It depends on whether you look at where the company is today or where it's going tomorrow.
7 Badly Bruised Stocks to Buy for the Tough-as-Nails Contrarian
02:07pm, Friday, 11'th Feb 2022
Although the market is full of potential pitfalls, risk-tolerant contrarians could consider these discounted stocks to buy. The post 7 Badly Bruised Stocks to Buy for the Tough-as-Nails Contrarian app
